Literature DB >> 10982404

PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis.

C W Wong1, G Wiedle, C Ballestrem, B Wehrle-Haller, S Etteldorf, M Bruckner, B Engelhardt, R H Gisler, B A Imhof.   

Abstract

PECAM-1/CD31 is a cell adhesion and signaling molecule that is enriched at the endothelial cell junctions. Alternative splicing generates multiple PECAM-1 splice variants, which differ in their cytoplasmic domains. It has been suggested that the extracellular ligand-binding property, homophilic versus heterophilic, of these isoforms is controlled by their cytoplasmic tails. To determine whether the cytoplasmic domains also regulate the cell surface distribution of PECAM-1 splice variants, we examined the distribution of CD31-EGFPs (PECAM-1 isoforms tagged with the enhanced green fluorescent protein) in living Chinese hamster ovary cells and in PECAM-1-deficient endothelial cells. Our results indicate that the extracellular, rather than the cytoplasmic domain, directs PECAM-1 to the cell-cell borders. Furthermore, coculturing PECAM-1 expressing and deficient cells along with transfection of CD31-EGFP cDNAs into PECAM-1 deficient cells reveal that this PECAM-1 localization is mediated by homophilic interactions. Although the integrin alphavbeta3 has been shown to interact with PECAM-1, this trans-heterophilic interaction was not detected at the borders of endothelial cells. However, based on cocapping experiments performed on proT cells, we provide evidence that the integrin alphavbeta3 associates with PECAM-1 on the same cell surface as in a cis manner.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982404      PMCID: PMC14979          DOI: 10.1091/mbc.11.9.3109

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  48 in total

1.  Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation.

Authors:  S A Bogen; H S Baldwin; S C Watkins; S M Albelda; A K Abbas
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

2.  Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain.

Authors:  N E Kirschbaum; R J Gumina; P J Newman
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

3.  Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18).

Authors:  M E Berman; W A Muller
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

4.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

Review 5.  Molecular and functional aspects of PECAM-1/CD31.

Authors:  H M DeLisser; P J Newman; S M Albelda
Journal:  Immunol Today       Date:  1994-10

Review 6.  Cellular and molecular aspects of PECAM-1.

Authors:  P J Newman; S M Albelda
Journal:  Nouv Rev Fr Hematol       Date:  1992

Review 7.  Oncogenes in the study of endothelial cell growth and differentiation.

Authors:  E F Wagner; W Risau
Journal:  Semin Cancer Biol       Date:  1994-04       Impact factor: 15.707

8.  Association of insulin receptor substrate-1 with integrins.

Authors:  K Vuori; E Ruoslahti
Journal:  Science       Date:  1994-12-02       Impact factor: 47.728

9.  Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development.

Authors:  H S Baldwin; H M Shen; H C Yan; H M DeLisser; A Chung; C Mickanin; T Trask; N E Kirschbaum; P J Newman; S M Albelda
Journal:  Development       Date:  1994-09       Impact factor: 6.868

10.  Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties.

Authors:  H M DeLisser; J Chilkotowsky; H C Yan; M L Daise; C A Buck; S M Albelda
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

View more
  26 in total

1.  Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils.

Authors:  Christopher J Kuckleburg; Sarah B Tilkens; Sentot Santoso; Peter J Newman
Journal:  J Immunol       Date:  2012-01-20       Impact factor: 5.422

2.  TCR stimulation drives cleavage and shedding of the ITIM receptor CD31.

Authors:  Giulia Fornasa; Emilie Groyer; Marc Clement; Jordan Dimitrov; Caroline Compain; Anh-Thu Gaston; Aditi Varthaman; Jamila Khallou-Laschet; Debra K Newman; Stéphanie Graff-Dubois; Antonino Nicoletti; Giuseppina Caligiuri
Journal:  J Immunol       Date:  2010-04-16       Impact factor: 5.422

3.  Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion.

Authors:  Chrystelle Lamagna; Paolo Meda; Guillaume Mandicourt; James Brown; Robert J C Gilbert; E Yvonne Jones; Friedemann Kiefer; Pilar Ruga; Beat A Imhof; Michel Aurrand-Lions
Journal:  Mol Biol Cell       Date:  2005-08-10       Impact factor: 4.138

4.  The alleles of PECAM-1.

Authors:  Melanie S Novinska; Bradley C Pietz; Thomas M Ellis; Debra K Newman; Peter J Newman
Journal:  Gene       Date:  2006-04-11       Impact factor: 3.688

5.  PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation.

Authors:  Purba Biswas; Sandra Canosa; David Schoenfeld; Jonathan Schoenfeld; Puyau Li; Lydia C Cheas; Jin Zhang; Alfredo Cordova; Bauer Sumpio; Joseph A Madri
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 6.  PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

Authors:  Sunyoung Park; Christine M Sorenson; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

7.  Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice.

Authors:  Donnasue Graesser; Anna Solowiej; Monika Bruckner; Emily Osterweil; Amy Juedes; Sandra Davis; Nancy H Ruddle; Britta Engelhardt; Joseph A Madri
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

8.  CRISPR-mediated deletion of the PECAM-1 cytoplasmic domain increases receptor lateral mobility and strengthens endothelial cell junctional integrity.

Authors:  Danying Liao; Heng Mei; Yu Hu; Debra K Newman; Peter J Newman
Journal:  Life Sci       Date:  2017-11-06       Impact factor: 5.037

9.  The expression of platelet endothelial cell adhesion molecule-1 in mouse primordial germ cells during their migration and early gonadal formation.

Authors:  Tomohiko Wakayama; Koichi Hamada; Miyuki Yamamoto; Toshio Suda; Shoichi Iseki
Journal:  Histochem Cell Biol       Date:  2003-05-08       Impact factor: 4.304

10.  PECAM-1 isoform-specific functions in PECAM-1-deficient brain microvascular endothelial cells.

Authors:  Terri A DiMaio; Nader Sheibani
Journal:  Microvasc Res       Date:  2007-10-17       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.